Social Media Ideas for Her2

UAB breast pathologists publish on reproducibility of HER2 testing in breast cancer

By: Kaitlin Davis From uab.edu Breast cancer is one of the leading causes of death for women worldwide. HER2, or human epidermal growth factor receptor 2, is a protein found on the...

HER2-targeted Therapy for Salivary Gland Cancer

Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use of HER2-targeted therapy for patients with metastat...

New Jazz cancer drug approval could drive blockbuster sales

Ziihera can now be used as an initial treatment for all HER2-positive gastroesophageal adenocarcinomas, dramatically expanding the drug’s market potential.

<![CDATA[FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Me...

5 Alarming Real-World Findings in HR-Positive, HER2-Low Metastatic Breast Cancer

From: oncodaily.com For patients with hormone receptor–positive metastatic breast cancer, the therapeutic landscape has expanded dramatically. CDK4/6 inhibitors transformed first-l...

mRNA Vaccine Paired With Radiotherapy Shrinks HER2-Positive Lung Tumors in Mice

A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a mouse model of HER...

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Tukysa Plus Trastuzumab and Pertuzumab]]>

FDA Grants Fast Track Designation to ETX-19477 in BRCA-Mutated HR+/HER2– Breast Cancer

From: .onclive.com The FDA has granted fast track designation to ETX-19477 for the treatment of adult patients with BRCA-mutated, hormone receptor (HR)–positive, HER2-negative unre...

AI Reads Routine Mammograms to Predict Breast Cancer HER2 Status Without Biopsy

A dual-center study shows that a deep learning radiomics model applied to routine mammograms can noninvasively predict HER2-positive and HER2-low breast cancer status, offering a p...

Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration

The companies' strategic collaboration will consist of two preclinical Hansoh ADC programs and “multiple” ADC programs based on Roche-identified targets, to be developed through Ha...